ShareChat Eyes 2027 IPO After Reaching Operational Profitability, Report Says 
UN Chief Urges Nations to Close $100 Million UNRWA Funding Gap 
RBA Minutes Signal Australia Central Bank Remains Ready to Raise Interest Rates if Inflation Persists 
South Korean Stocks Tumble as AI Chip Selloff Hits Asian Markets 
Oil Prices Rise as U.S.-Iran Talks Keep Geopolitical Risks in Focus 
Microsoft Reportedly Plans New Job Cuts Across Sales, Consulting, and Xbox 
Turkey Vehicle Sales Fall 11.4% in June as Auto Market Weakens 
Super Micro Employees Detained in Taiwan AI Server Export Investigation 
US Resumes Dollar Shipments to Iraq After Months-Long Suspension 
South Korea Warns Won Is Undervalued, Boosts FX Coordination With Japan 
SK Holdings, KKR Launch $1.3B Renewable Energy Venture in South Korea 
Oil Prices Slip as Iran Talks and Strong Supply Outlook Ease Market Concerns 
Buffett Delays Gates Foundation Donation Pending Epstein Ties Review 
Wall Street Futures Rise Ahead of JOLTS Data, Nike Earnings, and U.S.-Iran Talks 
Trump Administration Declines USMCA Renewal, Opens Talks on New Trade Changes 
NATO Albania Summit Faces Uncertainty as Trump, Defense Spending Concerns Loom 
US Jobs Report Preview: June Payroll Growth Seen Slowing as Fed Rate Decision Looms 
Japanese beer and beverage maker Kirin is selling its China soft drinks joint venture to a Chinese investment fund, Plateau Consumer, for $994 million to enhance its pharmaceutical business.
The sale covers Kirin’s entire 40 percent stake in China Resources Kirin Beverages.
Established in 2011, China Resources Kirin Beverage had been expanding its business in China, making bottled water and bottled tea.
The move was part of its recent decision to review its investment portfolio, including foreign operations, under a management plan that runs through 2024. It comes shortly after Kirin decided to pull out of a joint venture brewery in Myanmar.
Kirin is focusing on certain areas, including pharmaceuticals and health science as well as food and beverages.
The Tokyo-based company has been streamlining its operations to focus on pharmaceutical projects like developing drugs for diseases that have no existing treatments and working on what it calls LC-Plasma to offer products that help maintain immune systems.
Kirin is among Japan’s top beer brands, and still has various global operations, including Four Roses Distillery in the U.S. and San Miguel Brewery in the Philippines.
.
